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Abstract
Background: The molecular basis for neutrophil recognition of chemotactic peptides is their binding to specific G-
protein-coupled cell surface receptors (GPCRs). Human neutrophils express two pattern recognition GPCRs, FPR1 and 
FPR2, which belong to the family of formyl peptide receptors. The high degree of homology between these two 
receptors suggests that they share many functional and signal transduction properties, although they exhibit some 
differences with respect to signaling. The aims of this study were to determine whether FPR2 triggers a unique signal 
that allows direct influx of extracellular calcium without the emptying of intracellular calcium stores, and whether the 
gelsolin-derived PIP2-binding peptide, PBP10, selectively inhibits FPR2-mediated transient rise in intracellular Ca2+.
Results: The transient rise in intracellular Ca2+ induced by agonists for FPR1 or FPR2 in human neutrophils occurred 
also in the presence of a chelator of Ca2+ (EGTA). PBP10 inhibited not only FPR2-induced oxidase activity, but also the 
transient rise in intracellular Ca2+.
Conclusions: Ca2+ signaling mediated via FPR2 follows the same route as FPR1, which involves initial emptying of the 
intracellular stores. PBP10 inhibits selectively the signals generated by FPR2, both with respect to NADPH-oxidase 
activity and the transient rise in intracellular Ca2+ induced by agonist exposure.
Background
Neutrophil granulocytes are crucial for the outcome of
the "battle" between the innate immune system and
invading micro-organisms, and are key cells in the dam-
aged tissues at sites of infection and inflammation. Neu-
trophil responses to endogenous and exogenous
chemoattractants include locomotory responses, up-reg-
ulation of adhesion molecules, secretion of granule con-
stituents, and production of reactive oxygen species
(ROS), which are generated by the electron-transporting
NADPH-oxidase system [1-3]. The molecular basis for
cellular recognition of chemoattractants is their binding
to specific cell surface receptors [4-8]. Despite the struc-
tural variability of the numerous extracellular ligands,
many of them bind to (and activate) specific receptors
belonging to a large family of pertussis toxin-sensitive, G-
protein-coupled receptors (GPCRs). These receptors
share a high degree of amino acid sequence similarity,
and although they are activated by different agonists, they
transduce downstream signals that have many common
features. Nevertheless, it is clear that there are also
important differences between the receptor-ligand pairs
in terms of functional repertoires [9,10]. The pattern rec-
ognition formyl peptide receptor (FPR) family belongs to
the GPCR group of chemoattractant receptors, and
human neutrophil granulocytes express two members of
this family, i.e., FPR1 and FPR2 [4,11]. FPR2 was origi-
nally defined as an orphan receptor, and the gene was
cloned from an HL-60 cell cDNA library by low-strin-
gency hybridization with the FPR1  sequence [12-14].
Recently, several FPR2-specific ligands have been identi-
fied [4,11], including mitochondrial and microbial pep-
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tides [15,16], various antimicrobial peptides [17], the
acute phase protein serum amyloid A (SAA) [18,19], the
neurotoxic prion peptide fragment 106-126 [20], and syn-
thetic peptides, such as WKYMVM [21] and MMK-1
[22]. To date, no defined structure has been identified as
the determinant for FPR2 binding and activation,
although the close relationship between structural varia-
tion and function is illustrated by the fact that exchange
of the C-terminal L-methionine residue in WKYMVM
for the D-isomeric form expands the binding specificity
to encompass both FPR2 and FPR1 [23].
The many studies that have been performed on FPR1-
induced cell functions and signaling reveal that FPR1 sig-
naling has all the characteristics of a pertussis toxin-sen-
sitive GPCR. The activated receptor initiates a chain of
signaling events, starting with dissociation of the recep-
tor-associated G-protein, and subsequently, activation of
a number of downstream signaling pathways. In one of
these pathways, activation of phosphoinositide-specific
phospholipase C (PLC) generates a second messenger fol-
lowing cleavage of PIP2, and this is the starting signal for a
transient increase in cytosolic free calcium. Binding of
the cleavage product, IP3, to its receptor located on stor-
age organelles results in the release of Ca2+ from these
intracellular organelles and elevation consequent
increase in the concentration of free calcium ions in the
cytoplasm [Ca2+]i [24]. Emptying of the storage organelles
leads to the entry of extracellular Ca2+ through store-
operated calcium channels in the plasma membrane,
thereby prolonging the increase in [Ca2+]i [25,26].
Although our knowledge of the signal transduction
pathways utilized by FPR2 is currently somewhat limited,
the significant homology observed between FPR1 and
FPR2 (69% at the amino acid level) suggests that these
two receptors share signal transduction features. Accord-
ingly, we have previously shown that the functional
responses induced by the FPR2-specific agonist
WKYMVM is largely similar to (even indistinguishable
from) those induced by the prototype FPR1 agonist fMLF
[4]. However, fundamental differences between the sig-
naling profiles of these two receptors have been
described; the PIP2-binding peptide PBP10 [27] selec-
tively inhibits a signaling pathway triggered by FPR2,
without affecting signaling via FPR1 [28]. FPR2 has also
been shown to trigger a unique type of Ca2+ influx across
the plasma membrane [29]. It has been suggested that a
channel in the plasma membrane opens without involve-
ment of the intracellular storage organelles. Thus, the
influx of Ca2+ across the plasma membrane is not pre-
ceded by an increase in [Ca2+]i that originates from the
release of Ca2+ from the intracellular stores [29]. These
results point to two important differences in the signaling
mediated by the two FPRs in human neutrophils.
Whereas FPR2 triggers a unique calcium signal, which is
independent of the intracellular Ca2+  store-influenced
Ca2+ channels, and allows for the direct influx of extracel-
lular Ca2+, a PIP2-binding peptide inhibits FPR2-induced
(but not FPR1-induced) radical production by neutro-
phils. It is noteworthy that the influx of calcium induced
by FPR2 is apparently insensitive to PBP10 treatment
[28]. The mechanism underlying these differences is puz-
zling and it is thus of importance to verify or falsify the
observations.
In the present study, we characterize the neutrophil
responses to the FPR2-specific agonist WKYMVM. We
confirm the difference between FPR1-dependent and
FPR2-dependent activation of the neutrophil NADPH-
oxidase. However, in apparent discrepancy with previ-
ously published results [28,29], we show that the FPR2
agonist induces an increase in [Ca2+]i that involves Ca2+
release from intracellular stores, and this signaling path-
way is inhibited by the FPR2-specific inhibitor PBP10.
Results
The fMLF and WKYMVM peptides activate the NADPH-
oxidase in neutrophils
The NADPH-oxidase activities induced by the FPR1-spe-
cific peptide agonist fMLF and the FPR2-specific peptide
agonist WKYMVM were of similar magnitude (Fig. 1).
The kinetics of the responses induced by equimolar con-
centrations (10-7 M final concentrations) of these pep-
tides were also very similar, with peak activity observed
after approximately 1 minute. In accordance with earlier
findings [28], the WKYMVM-induced response was
inhibited by the membrane permeable polyphospho-
inositide-binding peptide rhodamine-B-QRLFQVKGRR
(PBP10), when it was added prior to activation. The neu-
trophil NADPH-oxidase activity was completely inhib-
ited by PBP10 when activation was triggered through
FPR2 (i.e., with WKYMVM), whereas PBP10 had no
inhibitory effect on the FPR1-mediated (i.e., fMLF-trig-
gered) neutrophil response (Fig 1). A molar ratio of ago-
nist to inhibitor of 1:10 was required to inhibit the
NADPH-oxidase response. Despite the very similar acti-
vation patterns of FPR1 and FPR2, functional differences
between these two highly homologous receptors become
apparent in the presence of PBP10.
The fMLF and WKYMVM peptides mobilize intracellular 
Ca2+ in neutrophils
It is well known that binding of a specific ligand to FPR1
results in PLC-dependent cleavage of PIP2, and that the
product, IP3, mobilizes calcium from intracellular storage
organelles. Thus, a transient increase in intracellular free
calcium was achieved when neutrophils were treated
with the FPR1 agonist fMLF (Fig 2). Moreover, a similarForsman and Dahlgren BMC Cell Biology 2010, 11:52
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response was obtained when neutrophils were treated
with the FPR2-specific ligand WKYMVM (Fig 2). In the
presence of extracellular calcium, the response is com-
posed of two phases: 1) an initial phase that is dependent
upon the release of Ca2+ from intracellular stores; and 2) a
second phase that is regulated by the stores [30] but relies
on the opening of plasma membrane channels.
The PIP2-binding peptide PBP10 inhibits the neutrophil 
calcium response to the FPR2 agonist WKYMVM
The direct transfer of the system used to determine oxy-
gen radical release to a system for determining transient
rises in intracellular calcium levels revealed the expected
insensitivity to PBP10 of the fMLF-induced neutrophil
response (Fig 3). However, the WKYMVM-triggered
response was only partly inhibited (Fig 3). This is in
accordance with previously published results [28]. It is
important to point out that there is no direct link
between the rise in [Ca2+]i and activation of the NADPH-
oxidase. This is clearly shown in desensitized cells in
which the cytoskeleton is disrupted by cytochalasin B.
These cells produce large quantities of oxygen radicals
(Fig 4B) that is inhibited by PBP10 (data not shown), but
i n  c o n t r a s t  t o  w h a t  i s  s e e n  wi t h  c o n t r o l  ( n o n - d e s e n s i -
tized) cells (Fig 4A and 4C) oxidase activation in the
desensitized cells is not associated with any rise in [Ca2+]i
(Fig 4D).
The sensitivity of the calcium measurement system is
very low when high concentrations of agonist (10-7 M) are
used, and we set out to determine if the insensitivity to
PBP10 of the WKYMVM induced response, is due to the
concentration used. We found that when the concentra-
tion of agonist was reduced (from 10-7 M, the final con-
centration used in Fig 3A) to 10 nM or 5 nM, the
response triggered by WKYMVM was completely inhib-
ited by PBP10 (Fig 3B). Lower concentrations of
WKYMVM did not evoke any Ca2+ response. In contrast
to the situation observed for WKYMVM, there was no
inhibition by PBP10 when the concentration of fMLF was
reduced to 1 nM, which was the lowest concentration to
induce a response (Fig 3B). These data clearly show that
the PBP10 peptide selectively inhibits the calcium
response mediated by FPR2.
The transient increases in intracellular Ca2+ induced by 
FPR1 and FPR2 rely on mobilization of Ca2+ from 
intracellular storage organelles
The signals generated by the binding of an FPR2-selective
agonist to a neutrophil have been shown to induce open-
ing of the calcium channels in the plasma membrane,
without mobilization of the Ca2+-storing organelles [29].
Accordingly, it has been shown that there is no increase
in the level of intracellular free calcium when extracellu-
lar calcium is lacking [29]. This contrasts with the signals
known to be generated by the fMLF/FPR1 ligand-recep-
tor-pairing. These signals induce the mobilization of Ca2+
from intracellular storage organelles, and an increase in
free intracellular calcium is also achieved in the absence
Figure 1 Neutrophil release of superoxide anions induced by WKYMVM and fMLF, which are agonists for FPR2 and FPR1, respectively. Neu-
trophils were stimulated with fMLF (A; 10-7 M final concentration) or WKYMVM (B; 10-7 M final concentration) in the absence or presence of PBP10 (A 
and B; 10-6 M final concentration). The agonists were added at time 0, and the release of superoxide was followed using a chemiluminescence tech-
nique. Light emission was measured with (broken lines) or without (solid lines) the addition of PBP10. One representative of at least 100 experiments 
performed is shown. Abscissa, time of study (min); ordinate, superoxide production, given as light emission and expressed as cpm × 10-6.Forsman and Dahlgren BMC Cell Biology 2010, 11:52
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of extracellular calcium (see below and [30]). To assess
the effects of calcium influx on neutrophil responses, the
calcium ions in the extracellular medium were removed
by treatment with EGTA immediately before the addition
of the receptor-specific agonist. The concentration of
EGTA used was that required to achieve a maximal inhi-
bition on ionomycin induced the NADPH-oxidase in
neutrophils (Fig 5), an activity that is dependent on the
influx of calcium from extracellular medium across the
plasma membrane. We found that WKYMVM induced
an increase in intracellular calcium in the absence of
extracellular calcium (Fig 6). Similar outcomes were
obtained when the FPR2 agonist MMK-1 (data not
shown) or fMLF (Fig 6) was used. The kinetics of the
WKYMVM-induced response resembled those of the
other peptides, and we could not confirm that the Ca2+
signaling induced by the FPR2 agonist induces a calcium
influx across the plasma membrane that is independent
of the emptying of the intracellular stores. Therefore, the
pattern of responses triggered through FPR2 is identical
to that mediated through FPR1.
Discussion
Human neutrophils express the formyl peptide receptor
family members FPR1 and FPR2, which share a high
degree of amino acid sequence identity. Despite the simi-
larities between the two receptors, the signaling events
that follow receptor occupancy and activation differ.
These differences may be related either to a specific ago-
nist or distinct difference(s) between the receptors [4,31].
We have previously shown that a receptor agonist that
binds to both FPR1 and FPR2 can trigger receptor-spe-
cific signals, and depending on the particular triggering
agonist, both receptors can either inhibit the functional
repertoire of the neutrophils or activate the same reper-
toire [32-34]. One of the early signals generated by acti-
Figure 2 The fMLF and WKYMVM peptides induce increases in intracellular calcium in neutrophils. Neutrophils loaded with Fura-2 were incu-
bated at 37°C for 5 minutes. PBP10 (10-6 M final concentration) was present for the initial 5 minutes (B and D), and the cells were stimulated with fMLF 
(A and B; 10-7 M final concentration) or WKYMVM (C and D; 10-7 M final concentration). The changes in cytosolic Ca2+ levels were determined by mea-
suring the fluorescence emitted at 509 nm following excitation at 340 nm and 380 nm. The results are presented as the ratios of the fluorescence 
intensities at 340 nm and 380 nm, and a representative experiment (of at least five repetitions) is shown.Forsman and Dahlgren BMC Cell Biology 2010, 11:52
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vated neutrophil GPCRs (including FPR1 and FPR2) is
the rapid rise of [Ca2+]i, which affects different cellular
functions. For a resting neutrophil, the free cytosolic cal-
cium concentration is maintained at a very low level
(approximately 100 nM) relative to the level in the extra-
cellular fluid (approximately 1 mM). To maintain this
concentration gradient, cells are equipped with ion
pumps that transport Ca2+ out of the cells as well as to the
intracellular calcium storing organelles, which contain
high levels of the calcium-binding protein calreticulin. It
is generally accepted that the main pathway for the con-
trol of rapid changes of [Ca2+]i in neutrophils is that rep-
resented by the capacitive model, which starts with the
production of inositol-1,4,5-trisphosphate (IP3). The
main pathway for IP3 production involves PLC-mediated
hydrolysis of membrane PIP2; the generated IP3 releases
calcium from intracellular stores by binding to specific
receptors on the intracellular storage organelles. The
depletion of the intracellular Ca2+ stores regulates the
opening of store-operated Ca2+ channels (SOC) in the
plasma membrane, thereby providing a rich source of
capacitive entry of calcium ions, originating from the
extracellular space [26,35,36]. With respect to the differ-
ent signaling properties of the FPRs, a recent report has
demonstrated that the regulatory mechanism that leads
to an increase in [Ca2+]i is unique to FPR2. Binding of an
agonist to either of the two FPRs results in a signaling
cascade, which in turn leads to an increase in intracellular
calcium through the influx of ions across the plasma
membrane. Whereas FPR1 influences the plasma mem-
brane channels through the emptying of intracellular
stores, as described above, FPR2 appears to generate a
signal that acts directly on the ion channels in the plasma
membrane so as to facilitate the influx of Ca2+ indepen-
dently of the filling status of the storage organelles [29].
Although we could not verify this difference in signal-
ing profile, we show that the signals from FPR1 and FPR2
initiate an increase in cytosolic free calcium derived from
the emptying of intracellular stores. The increase in
[Ca2+]i was achieved when the calcium in the extracellular
milieu was depleted through the addition of EGTA; these
data are in accordance with recent results from experi-
ments in which a much higher concentration (10-7 M) of
agonist was used [37]. With respect to the different sig-
naling properties of the two receptors, we recently
showed that FPR1 and FPR2 have different sensitivities to
PBP10 [28]. PBP10 inhibits FPR2-triggered activation of
the neutrophil NADPH-oxidase. However, when this sys-
tem was directly transferred to a calcium measurement
system, we found that the cytosolic increase in free Ca2+
was largely insensitive to PBP10.
In the present study, we confirm the difference between
FPR1-dependent and FPR2-dependent activation of the
neutrophil NADPH-oxidase. Moreover, we show that
PBP10 inhibits not only the oxidase activity, but also the
FPR2-induced increase in [Ca2+]i. The transient rise in
[Ca2+]i peaks at agonist concentrations that are much
lower than those used in the oxidase assay, and the inhib-
itory effects of PBP10 are, thus, disclosed only when the
concentration of the FPR2 agonist is reduced. No inhibi-
tory effect of PBP10 is seen when fMLF is used as the
agonist, irrespective of the concentration of the chemoat-
tractant used to activate the neutrophils.
The molecular mechanism underlying the effects of
PBP10 on FPR2-mediated induction of cell functions is
complex. PBP10 displays clearly higher specificity for
FPR2 than for FPR1, although this pattern of sensitivity is
not unique to this receptor [15,18]. The biochemical and
biophysical characterizations of the ten strategically orga-
nized basic and hydrophobic amino acids in PBP10,
which are also present in the gelsolin molecule, suggest
that it may interact with a broad range of negatively
charged phosphomonoesters and hydrophobic acyl
chains on anionic phospholipids. This implies that in
addition to its blocking/competing activities, which
involve proteins that are regulated by cellular phospho-
inositides, PBP10 may affect the functions of bioactive
and signaling lipids. Although the precise signal trans-
duction step that is disrupted by PBP10 remains to be
elucidated, the receptor-specific and signal-selective
effects of this peptide on neutrophil functions suggest
that it has potential applications as a tool to manipulate
and define how G-protein-coupled receptors produce
Figure 3 The rise in intracellular calcium induced by low concen-
trations of WKYMVM in neutrophils is inhibited by PBP10. Neutro-
phils loaded with Fura-2 were incubated at 37°C for 5 minutes. PBP10 
(10-6 M final concentration, broken lines) was present for the initial 5 
minutes (control cells were incubated without PBP10, solid lines), and 
the cells were stimulated with decreasing concentrations of fMLF (up-
per part of the figure) or WKYMVM (lower part of the figure). The 
changes in cytosolic Ca2+ levels were determined by measuring the 
fluorescence emitted at 509 nm following excitation at 340 nm and 
380 nm. A representative experiment of at least five performed is 
shown.Forsman and Dahlgren BMC Cell Biology 2010, 11:52
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and integrate the signals generated from activated recep-
tors, as well as to probe new signaling functions of poly-
phosphoinositides.
Conclusions
The neutrophil FPR family members FPR1 and FPR2
share 69% amino acid identity and mediate almost indis-
tinguishable cellular responses. Therefore, these two
FPRs use the same basic signaling pathways. Accordingly,
we show that Ca2+ signaling mediated via FPR2 follows
the same route as FPR1-mediated signaling, which
involves initial emptying of the intracellular stores. How-
ever, we found that the FPR2-mediated oxidase activity
and Ca2+ signaling pathway are inhibited by the FPR2-
specific inhibitor PBP10, whereas there is no inhibitory
effect of PBP10 when the high affinity FPR1 agonist fMLF
is used, irrespective of the concentration of the chemoat-
tractant used to activate the neutrophils. These data
clearly demonstrate that there is a fundamental difference
between the two very closely related receptor members,
in that one is PBP10-sensitive (FPR2) and the other
(FPR1) is PBP10-insensitive.
Methods
Peptides and reagents
The hexapeptide WKYMVM was synthesized and puri-
fied by Alta Bioscience (University of Birmingham, UK).
The formylated peptide N-formylmethionyl-leucyl-phe-
nylalanine (fMLF) was purchased from Sigma Chemical
Co. (St. Louis, MO). The peptides were dissolved in dim-
ethyl sulfoxide to a concentration of 10-2 M, and stored at
-70°C until use. Further dilutions were made in Krebs-
Ringer phosphate buffer that was supplemented with glu-
cose (10 mM), Ca2+ (1 mM), and Mg2+ (1.5 mM) (KRG).
Determination of changes in cytosolic calcium
Cells at the density of 1-3 × 106 per ml were washed with
Ca2+-free KRG and centrifuged at 220 × g. The cell pellets
Figure 4 Neutrophil superoxide anion production and intracellular calcium response induced by WKYMVM or cytochalasin B (cytB). Neu-
trophils were first incubated at 15°C for 10 min with 5 μg/ml CytB (A and C) or desensitized with 10-7 M WKYMVM (B and D) followed by incubation at 
37°C for another 10 minutes. The subsequent production of superoxide anion upon the addition of 10-7 M WKYMVM (A) or 5 μg/ml cytB (B) (indicated 
by the arrows) was measured by isoluminol amplified CL technique. Abscissa, time of study; ordinates, superoxide production given as given as cpm 
× 10-6.
The concentrations of intracellular calcium were determined upon stimulation with either cytB (C) or WKYMVM (D). Cells were first loaded with Fura-
2 (2 μM) before pre-incubation with WKYMVM (C) or CytB (D) at 15°C. The fluorescence levels corresponding to 1 mM and 1 nM are indicated by the 
bars. Abscissa, time of study; ordinates, intracellular Ca2+ changes given in arbitrary units. The curves are representative of at least four experiments.Forsman and Dahlgren BMC Cell Biology 2010, 11:52
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were resuspended at a density of 2 × 107 cells/ml in KRG
that contained 0.1% BSA, and loaded with 2 μM Fura 2-
AM (Molecular Probes, Eugene, OR) for 30 minutes at
room temperature. The cells were then diluted to twice
the original volume with RPMI 1640 culture medium
without phenol red (PAA Laboratories GmbH, Pasching,
Austria) and centrifuged. Finally, the cells were washed
once with KRG, and resuspended in the same buffer at a
density of 2 × 107 cells/ml. Calcium measurements were
carried out in a Perkin Elmer fluorescence spectropho-
tometer (LC50), with excitation wavelengths of 340 nm
and 380 nm, an emission wavelength of 509 nm, and slit
widths of 5 nm and 10 nm, respectively. The transient rise
in intracellular calcium is presented as the ratio of fluo-
rescence intensities (340 nm: 380 nm) detected. The mea-
suring cuvette contained catalase (2000 U), to counteract
inactivation of the chemoattractants by the MPO-H2O2-
system [38].
The concentration of EGTA required to achieve a cal-
cium-free environment was determined by titration of
the ionomycin-triggered production of oxidants by neu-
trophils resuspended in KRG that contained 1 mM Ca2+.
A small volume (10 μl) of EGTA-containing buffer was
added to the measuring vial, and 20 seconds later the
cells were activated by the addition of ionomycin (5 ×
10-7 M final concentration). The lowest concentration of
EGTA that inhibited more than 90% of the ionomycin-
induced response was used in subsequent studies to
ensure that no Ca2+ entered the cells across the plasma
membrane.
NADPH-oxidase activity measurements
Neutrophils (5 × 106 cells/ml) were incubated at 37°C for
5 minutes in an NADPH-oxidase measuring apparatus
(Berthold Co., Wildbad, Germany). The activity of the
cells was then using a luminol/isoluminol-enhanced
chemiluminescence (CL) system [39,40]. The extracellu-
lar CL activity was measured in a six-channel Biolumat
LB 9505, using disposable polypropylene tubes with a
0.90-ml reaction mixture. The mixture contained neutro-
phils (5 × l05 cells/ml), horse radish peroxidase (HRP; 4U)
and isoluminol (a cell-impermeable CL substrate; 2 × 10-5
M). The tubes were equilibrated at 37°C for 5 minutes in
the absence or presence of inhibitor, after which the stim-
ulus (0.1 ml) was added. The light emission was recorded
continuously.
To determine intracellular NADPH-oxidase activity
levels, we used mixtures that contained 5 × 105 neutro-
phils/ml, superoxide dismutase (SOD; a cell-imperme-
able superoxide scavenger; 200 U), catalase (2000 U), and
luminol (a cell-permeable CL substrate; 2 × 10-5 M). The
tubes were equilibrated at 37°C for 5 minutes in the lumi-
nometer, after which the stimulus (0.1 ml) was added, and
light emission was recorded continuously.
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Figure 5 Effects of increasing concentrations of EGTA on ionomy-
cin-induced production of superoxide anions by neutrophils. 
Neutrophils were stimulated with ionomycin (5 × 10-7 M final concen-
tration) without or with increasing concentrations of the Ca2+ chelator 
EGTA. EGTA was added to the samples 20 seconds before the addition 
of the ionophore (time 0). Intracellular production of superoxide was 
assessed using a luminol-amplified chemiluminescence technique.
Light emission was measured with or without EGTA, and a representa-
tive experiment of at least five performed is shown. Abscissa, time of 
study (minutes); ordinate, superoxide production, given as light emis-
sion and expressed as cpm × 10-6.
Figure 6 The fMLF and WKYMVM peptides induce a rise in intrac-
ellular calcium, even when extracellular calcium is depleted. Neu-
trophils loaded with Fura-2 were incubated at 37°C for 5 minutes. 
Depletion of extracellular calcium was achieved by the addition of 
EGTA (5 mM; broken lines) 20 seconds before addition of the agonist 
(time 0). The cells were then stimulated with decreasing concentra-
tions of WKYMVM (lower part of the figure) or fMLF (upper part of the 
figure). The responses of the control cells (incubated in the absence of 
EGTA and in the presence of 1 mM calcium) are shown as solid lines. 
The changes in cytosolic Ca2+ levels were determined by measuring 
the fluorescence emitted at 509 nm following excitation at 340 nm 
and 380 nm. The traces shown are from a representative experiment of 
at least five repetitions that gave similar results.Forsman and Dahlgren BMC Cell Biology 2010, 11:52
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